Patent details
EP3496753 Title: PD-1 ANTIBODY FORMULATION
Basic Information
- Publication number:
- EP3496753
- PCT Application Number:
- CN2017093141
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP178385134
- PCT Publication Number:
- WO2018028383
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PD-1 ANTIBODY FORMULATION
- French Title of Invention:
- FORMULATION D'ANTICORPS ANTI-PD-1
- German Title of Invention:
- PD-1-ANTIKÖRPERFORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 17/07/2017
- Grant date:
- 22/11/2023
- EP Publication Date:
- 19/06/2019
- PCT Publication Date:
- 15/02/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/11/2023
- EP B1 Publication Date:
- 22/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 17/07/2024
- Expiration date:
- 17/07/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/11/2023
- Name:
- Innovent Biologics (Suzhou) Co., Ltd.
- Address:
- 168 Dongping Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, China (CN)
Inventor
1
- Name:
- LIU, Xiaolin
- Address:
- China (CN)
2
- Name:
- CAO, Wei
- Address:
- China (CN)
3
- Name:
- LI, Junfeng
- Address:
- China (CN)
Priority
- Priority Number:
- PCT/CN2016/094094
- Priority Date:
- 09/08/2016
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- A61K 39/395; C07K 16/28; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202347
- Publication date:
- 22/11/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|